| Literature DB >> 21354972 |
Nicolas Couturier1, Florence Bucciarelli, Ramil N Nurtdinov, Marc Debouverie, Christine Lebrun-Frenay, Gilles Defer, Thibault Moreau, Christian Confavreux, Sandra Vukusic, Isabelle Cournu-Rebeix, Robert H Goertsches, Uwe K Zettl, Manuel Comabella, Xavier Montalban, Peter Rieckmann, Frank Weber, Bertram Müller-Myhsok, Gilles Edan, Bertrand Fontaine, Lennart T Mars, Abdelhadi Saoudi, Jorge R Oksenberg, Michel Clanet, Roland S Liblau, David Brassat.
Abstract
The tyrosine kinase 2 variant rs34536443 has been established as a genetic risk factor for multiple sclerosis in a variety of populations. However, the functional effect of this variant on disease pathogenesis remains unclear. This study replicated the genetic association of tyrosine kinase 2 with multiple sclerosis in a cohort of 1366 French patients and 1802 controls. Furthermore, we assessed the functional consequences of this polymorphism on human T lymphocytes by comparing the reactivity and cytokine profile of T lymphocytes isolated from individuals expressing the protective TYK2(GC) genotype with the disease-associated TYK2(GG) genotype. Our results demonstrate that the protective C allele infers decreased tyrosine kinase 2 activity, and this reduction of activity is associated with a shift in the cytokine profile favouring the secretion of Th2 cytokines. These findings suggest that the rs34536443 variant effect on multiple sclerosis susceptibility might be mediated by deviating T lymphocyte differentiation toward a Th2 phenotype. This impact of tyrosine kinase 2 on effector differentiation is likely to be of wider importance because other autoimmune diseases also have been associated with polymorphisms within tyrosine kinase 2. The modulation of tyrosine kinase 2 activity might therefore represent a new therapeutic approach for the treatment of autoimmune diseases.Entities:
Mesh:
Substances:
Year: 2011 PMID: 21354972 DOI: 10.1093/brain/awr010
Source DB: PubMed Journal: Brain ISSN: 0006-8950 Impact factor: 13.501